AdipoGen Life Sciences has released the Nampt (Visfatin/PBEF) (human) intracellular ELISA kit.
Nampt is considered a key player in inflammatory arthritis and is also of interest in diabetes, obesity, sepsis, IBD, Crohn’s disease and pre-eclampsia research. It is the rate-limiting enzyme of the mammalian nicotinamide adenine dinucleotide biosynthesis pathway from nicotinamide to nicotinamide mononucleotide. It shares homology with Visfatin, which is found in human sera and secreted from differentiated adipocytes.
The Nampt ELISA kit is a sandwich-based colorimetric assay that is suitable for the in vitro quantitative determination of human Nampt, within the range of 0.25 to 16 ng/mL, in cell lysates or cell-based assays (screening). Nampt is recognised by the addition of a purified polyclonal antibody specific for Nampt in a 96-well plate.
Phone: 02 9698 2022
Beckman Coulter Life Sciences Basophil Activation Test (BAT) for food allergy research
Beckman Coulter Life Sciences introduces its next-generation Basophil Activation Test (BAT) to...
TopoGEN Topoisomerase Assay Kits
TopoGEN provides innovative reagents and kits for topoisomerase research and mechanism-based drug...
Alamar Biosciences NULISAseq Mouse Panel 120 for protein biomarker analysis
The multiplex panel encompasses a wide selection of proteins essential for studying key...
